1. Home
  2. SKIN vs IMMP Comparison

SKIN vs IMMP Comparison

Compare SKIN & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKIN
  • IMMP
  • Stock Information
  • Founded
  • SKIN 1997
  • IMMP 1987
  • Country
  • SKIN United States
  • IMMP Australia
  • Employees
  • SKIN N/A
  • IMMP N/A
  • Industry
  • SKIN Package Goods/Cosmetics
  • IMMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKIN Consumer Discretionary
  • IMMP Health Care
  • Exchange
  • SKIN Nasdaq
  • IMMP Nasdaq
  • Market Cap
  • SKIN 300.6M
  • IMMP 251.8M
  • IPO Year
  • SKIN N/A
  • IMMP N/A
  • Fundamental
  • Price
  • SKIN $1.68
  • IMMP $1.86
  • Analyst Decision
  • SKIN Buy
  • IMMP Buy
  • Analyst Count
  • SKIN 3
  • IMMP 1
  • Target Price
  • SKIN $2.42
  • IMMP $7.00
  • AVG Volume (30 Days)
  • SKIN 1.1M
  • IMMP 93.6K
  • Earning Date
  • SKIN 11-11-2025
  • IMMP 10-21-2025
  • Dividend Yield
  • SKIN N/A
  • IMMP N/A
  • EPS Growth
  • SKIN N/A
  • IMMP N/A
  • EPS
  • SKIN N/A
  • IMMP N/A
  • Revenue
  • SKIN $310,064,000.00
  • IMMP $3,306,742.00
  • Revenue This Year
  • SKIN N/A
  • IMMP $16.82
  • Revenue Next Year
  • SKIN $5.87
  • IMMP N/A
  • P/E Ratio
  • SKIN N/A
  • IMMP N/A
  • Revenue Growth
  • SKIN N/A
  • IMMP 31.28
  • 52 Week Low
  • SKIN $0.78
  • IMMP $1.32
  • 52 Week High
  • SKIN $2.69
  • IMMP $2.71
  • Technical
  • Relative Strength Index (RSI)
  • SKIN 31.71
  • IMMP 61.34
  • Support Level
  • SKIN $1.91
  • IMMP $1.64
  • Resistance Level
  • SKIN $2.56
  • IMMP $1.89
  • Average True Range (ATR)
  • SKIN 0.15
  • IMMP 0.08
  • MACD
  • SKIN -0.08
  • IMMP 0.02
  • Stochastic Oscillator
  • SKIN 0.98
  • IMMP 86.21

About SKIN The Beauty Health Company

The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Share on Social Networks: